DB
AVNS

Dmitry Balyasny’s Avanos Medical AVNS Stock Holding History

Dmitry Balyasny’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.4M Buy
+739,829
New +$17.3M 0.02% 764
2025
Q2 		– Sell
-86,229
Closed -$1.24M – 2812
2025
Q1 		$1.24M Buy
86,229
+71,620
+490% +$1.12M ﹤0.01% 1908
2024
Q4 		$233K Buy
+14,609
New +$289K ﹤0.01% 2485
2023
Q3 		– Sell
-13,182
Closed -$337K – 2246
2023
Q2 		$337K Buy
+13,182
New +$347K ﹤0.01% 1960
2022
Q4 		– Sell
-30,836
Closed -$672K – 2772
2022
Q3 		$672K Sell
30,836
-323,173
-91% -$8.44M ﹤0.01% 1949
2022
Q2 		$9.68M Buy
354,009
+65,163
+23% +$1.87M 0.03% 663
2022
Q1 		$9.68M Sell
288,846
-19,063
-6% -$614K 0.03% 706
2021
Q4 		$10.7M Sell
307,909
-23,085
-7% -$746K 0.04% 616
2021
Q3 		$10.3M Buy
+330,994
New +$11.2M 0.04% 565
2020
Q4 		– Sell
-207,941
Closed -$6.91M – 1313
2020
Q3 		$6.91M Buy
+207,941
New +$6.64M 0.05% 503
2019
Q4 		– Sell
-6,296
Closed -$236K – 1152
2019
Q3 		$236K Buy
+6,296
New +$240K ﹤0.01% 1058
2018
Q3 		– Sell
-6,317
Closed -$362K – 1655
2018
Q2 		$362K Buy
+6,317
New +$334K ﹤0.01% 1450
2018
Q1 		– Sell
-185,594
Closed -$8.57M – 1927
2017
Q4 		$8.57M Buy
+185,594
New +$8.53M 0.03% 682

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Dmitry Balyasny's AVNS Position: Q2 2026 in Review

Dmitry Balyasny opened a new position in Avanos Medical (AVNS) in Q2 2026: 739,829 shares worth $18.4M. The stake represents 0.02% of the portfolio and ranks #764 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in AVNS as recently as Q1 2025.

Dmitry Balyasny first reported a position in AVNS in Q4 2017 and has held it in 13 quarters since. 284 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Dmitry Balyasny held 739,829 shares of Avanos Medical worth $18.4M as of Q2 2026.
  • Avanos Medical was a new Dmitry Balyasny position in Q2 2026.
  • Avanos Medical made up 0.02% of Dmitry Balyasny's portfolio in Q2 2026, its #764 holding.
  • Dmitry Balyasny first reported a position in Avanos Medical in Q4 2017 and has held it in 13 quarters since.
  • 284 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.